POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.16.2021, 4:18pm CEST, WHO):   U.S. 163,311    India 30,570    Brazil 13,406    United Kingdom 29,873    Russia 19,594    Turkey 28,224    France 8,686    Iran 19,731    Argentina 3,017    Columbia 1,435    Spain 1,590    Italy 4,826    Germany 12,925    Mexico 12,929    South Africa 4,667    Ukraine 5,744    Philippines 16,989    Malaysia 19,495    Netherlands 2,402    Iraq 3,895    Japan 6,686    Canada 4,049    Thailand 13,897    Pakistan 2,527    Sweden 1,105    Romania 4,441    Portugal 1,247    Morocco 2,785    Serbia 7,628    Cuba 7,437    Austria 2,638    Vietnam 10,585    Greece 2,406    Georgia 2,176    Guatemala 4,230    Belarus 1,923    Costa Rica 1,376    Bulgaria 1,862    Azerbaijan 2,064    Croatia 1,369    Ireland 1,181    Honduras 1,329    Libya 1,433    Ethiopia 1,687    Lithuania 1,330    South Korea 1,943    Slovenia 1,364    Moldova 1,153    Bosnia and Herzegovina 1,030    Burundi 1,807    China 86    Singapore 807    New Zealand 18    Australia 1,699   

Cancer cells play hide-and-seek with immune system

Staff writer |
When the immune system attacks cancer, the tumor modifies itself to escape the immune reaction. Researchers at Leiden, Universiteit published on this subject in Nature.

Article continues below

The researchers discovered that as a result of the immune reaction new tumor cells are formed that have far fewer or even none of the DNA modifications that the immune system can recognise.

This is how the tumor tries to escape the immune reaction. However, the immune system can learn to recognise new DNA modifications.

By treating cancer patients with a different form of immunotherapy, it should be possible to switch off the modified tumor cells as well, the researchers conclude.

Immunotherapy is a cancer treatment whereby the patient's own immune system is activated to trace and destroy cancer cells.

What to read next

Tumors contain the seeds of their own destruction
How cancer’s 'invisibility cloak' works
Improved method of engineering T-cells to attack cancer